A Phase 4 interventional study of Hyaluronic acid filler/IMD1 basic in Nasolabial Folds, sponsored by Merz Pharmaceuticals GmbH. Completed at 1 site in Germany. Open to participants aged 30 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-02-07.
Sponsored by Merz Pharmaceuticals GmbH · Phase 4, Interventional, and Treatment
Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.
Merz Pharmaceuticals GmbH is the lead sponsor of 60 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Severity rating scale assessed by independent rater
This study is completed, as verified in Feb 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Merz Pharmaceuticals GmbH